A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients
A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients
Not yet recruiting · NCT03833206 · Registry updated 2026-04-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-04-20 | NCT03833206 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| American BriVision Corporation | 3 |
| BioLite, Inc. | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars-Sinai Health System | Los Angeles | United States | 1 |